Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

23.72
-0.2200-0.92%
Post-market: 23.65-0.0700-0.30%19:51 EDT
Volume:2.72M
Turnover:65.23M
Market Cap:2.66B
PE:-23.52
High:24.68
Open:23.83
Low:23.30
Close:23.94
Loading ...
May 22, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 25, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 24, 2024

Major Issues Report

Form 8-K - Current report
Mar 26, 2024

Major Issues Report

Form 8-K - Current report
Mar 04, 2024

Major Issues Report

Form 8-K - Current report
Mar 01, 2024

Major Issues Report

Form 8-K - Current report
Feb 27, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 07, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 07, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 07, 2024

Major Issues Report

Form 8-K - Current report
Feb 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities